35.1（小鼠雜交瘤細(xì)胞抗CD2）
CBP61115
詢(xún) 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | 35.1 |
| Background: | Spleen cells were fused with NSI/1 myeloma cells. |
| Species: | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Tissue: | N/A |
| Disease: | N/A |
| Gender: | N/A |
| Morphology: | lymphoblast |
| Growth Mode: | suspension |
| Doubling Time: | N/A |
| DNA Profile: | N/A Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS+0.05 mM 2-mercaptoethanol 35.1完全培養(yǎng)基，# CBP61115M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | N/A |
| Receptor Expression: | N/A |
| Oncogene: | N/A |
| Genes Expressed: | immunoglobulin; monoclonal antibody; against human CD2 |
| Cellular Products: | immunoglobulin; monoclonal antibody; against human CD2 |
| Tumor Formation: | N/A |
| Comments: | Animals were immunized with human T lymphocytes that had been activated with phorbol myristic acid (PMA). Spleen cells were fused with NSI/1 myeloma cells. The antibody reacts with the human T cell surface protein Tp50 (CD2). The antibody inhibits T cell proliferative responses and cytotoxicity, but does not inhibit antibody mediated cellular cytotoxicity. For more information, please contact us (4008-750-250). |
